| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/14/2005 | EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation |
| 09/14/2005 | EP1572065A2 Method and pharmaceutical composition for the treatment of multiple sclerosis |
| 09/14/2005 | EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/14/2005 | EP1571970A2 Diagnosis and monitoring of diseases |
| 09/14/2005 | EP1571909A2 Optimized multi-epitope constructs and uses thereof |
| 09/14/2005 | EP1257293B1 Immunomodulatory effective compositions, methods for the production thereof and their use |
| 09/14/2005 | EP1137422B1 Use of human prostate cell lines for the treatment of prostate cancer |
| 09/14/2005 | EP1092028B1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 09/14/2005 | EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors |
| 09/14/2005 | EP1070255B1 Method to detect the complex of igfbp-3 with igf and/or als |
| 09/14/2005 | EP1033995B1 Whole or disrupted insect cells as adjuvant for antigens |
| 09/14/2005 | EP0833933B1 A vector and method for producing influenza hemagglutinin |
| 09/14/2005 | CN1668750A Her-2/neu DNA vaccine having anti-cancer activity |
| 09/14/2005 | CN1668746A MUC-1 antigen with reduced number of VNTR repeat units |
| 09/14/2005 | CN1668745A transgenic animal for expressing |
| 09/14/2005 | CN1668736A GM-negative EHV-mutants without heterologous elements |
| 09/14/2005 | CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 09/14/2005 | CN1668641A 截短tau蛋白 Truncated tau protein |
| 09/14/2005 | CN1668638A Hsp70 from arthrobacter |
| 09/14/2005 | CN1668637A Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
| 09/14/2005 | CN1668636A Recombinant production of mixtures of antibodies |
| 09/14/2005 | CN1668633A IgG Fc/HIV-gp120/C3d fusion protein |
| 09/14/2005 | CN1668630A Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/14/2005 | CN1668331A Hapten-carrier conjugates and uses thereof |
| 09/14/2005 | CN1668329A 疫苗组合物 Vaccine compositions |
| 09/14/2005 | CN1668328A Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 09/14/2005 | CN1668275A Composition and method for controlled release injections |
| 09/14/2005 | CN1667416A Diagnostics and therapeutics for glaucoma |
| 09/14/2005 | CN1666996A Fusion protein, gene encoding same, and expression method and use thereof |
| 09/14/2005 | CN1666779A Debilitating agent for highly toxic chicken coccidian and its preparation |
| 09/14/2005 | CN1219055C A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/14/2005 | CN1219054C Structure for recombinant adenovirus with double killer function and application in tumor treatment |
| 09/14/2005 | CN1219050C Transgenic saline algae bio-reactor |
| 09/14/2005 | CN1218751C Two-element active antibody preparation and its preparing process |
| 09/14/2005 | CN1218750C Recombinant hepatitis B BCG vaccine combined vaccine for intradermal injection and its preparation method |
| 09/14/2005 | CN1218749C Recombination protein vaccine for preventing animal aphtha virus infection and uses thereof |
| 09/14/2005 | CN1218748C Foreign duck liver ichthyophthirius active vaccine and preparation method thereof |
| 09/13/2005 | US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof |
| 09/13/2005 | US6943239 Antigenic fusionprotein carrying Galα1,3Gal epitopes |
| 09/13/2005 | US6943236 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 09/13/2005 | US6943233 Cyclic peptides and aids vaccines |
| 09/13/2005 | US6943152 DNA vaccine-PCV |
| 09/13/2005 | US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids |
| 09/13/2005 | US6943148 Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity |
| 09/13/2005 | US6943015 Large scale production of packaged alphavirus replicons |
| 09/13/2005 | US6943012 Helper dependent adenoviral vector system and methods for using the same |
| 09/13/2005 | US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 09/13/2005 | US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C |
| 09/13/2005 | US6942982 FEBP1 protein vector host cells and method for making FEBP1 protein |
| 09/13/2005 | US6942981 Method of determining interactions with PDZ-domain polypeptides |
| 09/13/2005 | US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel |
| 09/13/2005 | US6942978 Diagnosing cancer by detecting a TADG-12 protein in biological sample, immunoaffinity to an antibody, bioassay, immunoassay |
| 09/13/2005 | US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 09/13/2005 | US6942866 Hepatitis viral protein for use in treatment of viral diseases |
| 09/13/2005 | US6942864 use of live, recombinant leporipox virus comprising exogenous DNA, which is operably linked to at least one expression control element and which is incorporated into non-essential region of virus genome, in manufacture of vector vaccine |
| 09/13/2005 | US6942863 Polypeptide for use the prevention of infections associated with tissue grafting |
| 09/13/2005 | US6942862 Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins |
| 09/13/2005 | US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli |
| 09/13/2005 | CA2175476C Opioid receptor: compositions and methods |
| 09/13/2005 | CA2173254C Immunological tolerance-inducing agent |
| 09/12/2005 | CA2460861A1 Combination of transplantation and oncolytic virus treatment |
| 09/09/2005 | WO2005083385A2 Method of evaluating the therapeutic potential of a vaccine for mucosal administration |
| 09/09/2005 | WO2005083088A1 E.coli o157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 09/09/2005 | WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha |
| 09/09/2005 | WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof |
| 09/09/2005 | WO2005083074A1 Tumor antigen peptides |
| 09/09/2005 | WO2005083072A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli |
| 09/09/2005 | WO2005083064A1 Cancerous disease modifying antibodies |
| 09/09/2005 | WO2005083063A1 Cancerous disease modifying antibodies |
| 09/09/2005 | WO2005083062A1 Cell vaccine |
| 09/09/2005 | WO2005082930A2 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
| 09/09/2005 | WO2005082929A2 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays |
| 09/09/2005 | WO2005082894A1 Cell targeting conjugates |
| 09/09/2005 | WO2005082415A2 Inhibitors of insulin-like growth factor receptor-1 for inhibiting tumor cell growth |
| 09/09/2005 | WO2005082411A1 Method of treating abnormal cell growth using c-met and-tor inhibitors |
| 09/09/2005 | WO2005082409A1 Target for b-cell disorders |
| 09/09/2005 | WO2005082408A2 A vaccine composition comprising an immunoadjuvant compound consisting of a rho gtpase family activator |
| 09/09/2005 | WO2005082407A1 Use of quercetin and resveratrol to treat and prevent oral cancer |
| 09/09/2005 | WO2005082377A1 INHIBITOR FOR LOWERING IN THE ACTIVITY OF ANTIHUMAN TNF-α ANTIBODY |
| 09/09/2005 | WO2005082339A2 Medicaments and methods for treating headache |
| 09/09/2005 | WO2005081982A2 Methods for preparing t-cells for cell therapy |
| 09/09/2005 | WO2005081980A2 Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts |
| 09/09/2005 | WO2005081872A2 Methods and compositions comprising supramolecular constructs |
| 09/09/2005 | WO2005081854A2 Egf receptor epitope peptides and uses thereof |
| 09/09/2005 | WO2005081847A2 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides |
| 09/09/2005 | WO2005081749A2 Neutralizing human antibodies to anthraxtoxin |
| 09/09/2005 | WO2005081711A2 Monomethylvaline compounds capable of conjugation to ligands |
| 09/09/2005 | WO2005070452A3 Methods for reducing somatic cell count in milky administration of mutated enterotoxins |
| 09/09/2005 | WO2005063991A3 Live genetically attenuated malaria vaccine |
| 09/09/2005 | WO2005047483A3 Renta: an hiv immunogen and uses thereof |
| 09/09/2005 | WO2005046614A3 System for treating and preventing breast cancer |
| 09/09/2005 | WO2005044996A3 Chimeric receptors with 4-1bb stimulatory signaling domain |
| 09/09/2005 | WO2005037222A3 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 09/09/2005 | WO2005034992A3 Hiv vaccines based on env of multiple clades of hif |
| 09/09/2005 | WO2005034733A3 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 09/09/2005 | WO2005033265A3 Optimized multi-epitope constructs and uses thereof |
| 09/09/2005 | WO2005030802A3 Antigens for an east coast fever vaccine |
| 09/09/2005 | WO2005012330A3 AMYLOID β-PEPTIDE AND METHODS OF USE |
| 09/09/2005 | WO2005007804A3 Anthrax conjugate vaccine and antibodies |
| 09/09/2005 | WO2005000898A3 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |